Economic analysis consistently shows that treating cattle lameness early and effectively pays financially as well as improving welfare, demonstrating that welfare and profitability align in this area.
The economics of cattle lameness treatment represent an unusual alignment: the welfare case for early, effective treatment is matched by a compelling financial case, meaning welfare and profit interests point in the same direction. Yet lameness prevalence remains high on many farms, suggesting that the economic argument alone does not drive behavior change. The barriers include time pressure (treatment takes labor), tendency to normalize moderate lameness as 'not bad enough yet', and short-term cost aversion overriding long-term economic analysis. Welfare advocacy that presents both the humanitarian and economic case simultaneously may be more effective than either alone, particularly with commercial livestock producers who are motivated by profitability. The cost-of-disease economic framework also helps demonstrate to farm lenders and investors that welfare improvement is a business investment rather than a cost.